Details
Stereochemistry | ACHIRAL |
Molecular Formula | C3H5N2.C3H4N2.C2H6OS.4Cl.Ru |
Molecular Weight | 458.18 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | [H2im][trans-RuCl4(dmso-S)(Him)] |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].[Cl-].[Cl-].[Ru+3].C[S+](C)[O-].N1C=CN=C1.N2C=C[NH+]=C2
InChI
InChIKey=RJZBTXZRLXLLKO-UHFFFAOYSA-K
InChI=1S/2C3H4N2.C2H6OS.4ClH.Ru/c2*1-2-5-3-4-1;1-4(2)3;;;;;/h2*1-3H,(H,4,5);1-2H3;4*1H;/q;;;;;;;+3/p-3
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
60487Z56XW
Created by
admin on Sat Dec 16 11:17:36 GMT 2023 , Edited by admin on Sat Dec 16 11:17:36 GMT 2023
|
PRIMARY | |||
|
9890346
Created by
admin on Sat Dec 16 11:17:36 GMT 2023 , Edited by admin on Sat Dec 16 11:17:36 GMT 2023
|
PRIMARY | |||
|
NAMI-A
Created by
admin on Sat Dec 16 11:17:36 GMT 2023 , Edited by admin on Sat Dec 16 11:17:36 GMT 2023
|
PRIMARY | NAMI-A and KP1019 are two ruthenium anticancer agents that have entered clinical trials. NAMI is an acronym for "New Anti-tumour Metastasis Inhibitor", while the -A suffix indicates that this is the first of a potential series. Ruthenium, unlike traditional platinum complexes such as cisplatin, shows greater resistance to hydrolysis and more selective action on tumors. | ||
|
201653-76-1
Created by
admin on Sat Dec 16 11:17:36 GMT 2023 , Edited by admin on Sat Dec 16 11:17:36 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD